Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | Pregnancy outcomes in CML patients

Ekaterina Chelysheva • 14 Jun 2019
EHA 2019
Chronic Myeloid Leukemia Leukemia

Family planning is an important issue for chronic myeloid leukemia (CML) patients of childbearing potential, because they have a normal lifespan in the era of tyrosine kinase inhibitors; however, data on pregnancy cases in CML patients are scarce. Here, Ekaterina Chelysheva from the National Research Center for Hematology, Moscow, Russian Federation, discusses pregnancy outcomes in CML patients from an analysis of worldwide European Leukemia Net (ELN) registry data. This press briefing was recorded at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals